featured
Assessing the Prognostic Importance of Regression in Patients With Primary Cutaneous Melanoma Undergoing Sentinel Lymph Node Biopsy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single-institutional cohort study
J Am Acad Dermatol 2023 Dec 01;[EPub Ahead of Print], NB Wagner, SM Knierim, F Luttermann, G Metzler, AS Yazdi, J Bauer, M Gassenmaier, A Forschner, U Leiter, T Amaral, C Garbe, TK Eigentler, S Forchhammer, L FlatzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.